BO
BMY icon

Bach Option’s Bristol-Myers Squibb BMY Stock Holding History

Bach Option’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,450
Closed -$308K – 83
2019
Q1 		$308K Buy
+6,450
New +$321K 0.13% 75
2016
Q4 		– Sell
-5,330
Closed -$287K – 169
2016
Q3 		$287K Buy
+5,330
New +$342K 0.13% 137

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bach Option's BMY Position: Q2 2019 in Review

Bach Option sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 6,450 shares — an estimated $308K sold.

Bach Option first reported a position in BMY in Q3 2016 and held it in 2 quarters. The position peaked at $308K in Q1 2019. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

  • Bach Option reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
  • Bach Option sold 6,450 Bristol-Myers Squibb shares in Q2 2019, an estimated $308K.
  • Bach Option first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 2 quarters.
  • Bach Option's Bristol-Myers Squibb position peaked at $308K in Q1 2019.
  • 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Bach Option's 13F filing for Q2 2019, filed 25 Jul 2019.